RAC 6.14% $1.82 race oncology ltd

RAC - Charts & Price Action, page-18015

  1. 2,633 Posts.
    lightbulb Created with Sketch. 2384
    Bisantrene RC110 is a clinic ready drug for solid tumours and it has been such since before it was approved 40 years ago. Not only is it clinic ready, clinical results have just been released 186 hours ago that have been called "stunning", "impressive", and "remarkable"!

    They are applying full commitment to getting their new version, RC220, into the clinic, right now.

    No need to talk about the past - it's behind us, it has been acknowledged, and the team at Race Oncology are full speed ahead on progress and strategy for the best outcome for patients and shareholders.


    The number one cash contributing individual who has put the most equity capital into RAC is Dr T and he's not only committed to the investment, he's also working on it. I know the individuals who, along with their direct associates, have contributed the second most cash for the delivery of RAC's program. Also on this forum is the private individual who has spent more of their own money than anyone else acquiring RAC shares. These people are comfortable and committed.

    Every single member of the Le Raz team rates their RAC Investment Experience as positive; even "Joel" who hardly ever turns up.

    Everyone, cheer up if you can, and have a great weekend! "Joel" sends his love and best wishes.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.82
Change
0.105(6.14%)
Mkt cap ! $309.0M
Open High Low Value Volume
$1.85 $1.96 $1.75 $862.1K 467.9K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.82 5000 1
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.